Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
17 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250717111986/en/Alnylam-to-Webcast-Conference-Call-Discussing-Second-Quarter-2025-Financial-Results
18 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250618527794/en/Alnylam-Announces-Promotion-of-Pushkal-Garg-to-Chief-Research-and-Development-Officer
10 Jun 2025
// BIOSAPCE
https://www.biospace.com/press-releases/alnylam-receives-european-commission-approval-for-amvuttra-vutrisiran-for-the-treatment-of-attr-amyloidosis-with-cardiomyopathy
28 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250528617673/en/Alnylam-to-Webcast-Presentation-at-Goldman-Sachs-46th-Annual-Global-Healthcare-Conference
20 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250520029083/en/Alnylam-Issues-2024-Corporate-Responsibility-Report
17 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250517369489/en/AMVUTTRA-vutrisiran-Significantly-Reduces-Mortality-and-a-Range-of-Important-Cardiovascular-Events-in-Patients-with-ATTR-Amyloidosis-with-Cardiomyopathy-Additional-Data-from-HELIOS-B
ABOUT THIS PAGE